The pharmaceutical drug delivery landscape in 2026 features fundamental changes including fine-increment user-settable oral dosing with systems like Adare Pharma Solutions’ Diffucaps + AbbatiaLabs’ POWDOSE for variable minitablet dispensing.1
Reformulation of intravenous therapies to subcutaneous delivery is advancing, especially in oncology and immunology, with examples like Keytruda, Darzalex, and Herceptin for improved patient convenience.1
Gas-powered autoinjectors from Windgap Medical offer flatter force profiles, flexibility for large-volume subcutaneous injections, and support for dual-liquid sequential delivery.1
Dual-chamber systems like Kindeva’s DuoDote® (FDA-approved for nerve agent treatment) and Credence MedSystems’ syringe enable sequential multi-liquid delivery and reconstitution.1
Upcoming 2026 conferences such as Drug Delivery Summit, PODD, and American Drug Delivery & Formulation Summit highlight innovations in controlled-release, nanocarriers, transdermal patches, and overcoming the blood-brain barrier.234
Sources:
1. https://www.ondrugdelivery.com/trends-for-2026/